---
title: 'Senior Director, Corporate & Commercial IT Business Systems at IMVT Corporation'
canonical: 'https://feeny.ai/job/senior-director-corporate-commercial-it-business-systems-imvt-corporation-remote-vw2vm2e990w9'
type: 'job'
last_seen: '2026-10-30'
---

# Senior Director, Corporate & Commercial IT Business Systems at IMVT Corporation

- **Company:** IMVT Corporation
- **Location:** Remote
- **Compensation:** $260k–$295k
- **Work type:** remote
- **Posted:** 2026-10-26
- **Last confirmed live:** 2026-10-30
- **Apply:** https://job-boards.greenhouse.io/imvtcorporation/jobs/6235285004

## Job description

Immunovant, Inc. is a clinical-stage biopharmaceutical company dedicated to enabling normal lives for people with autoimmune diseases. As trailblazers in FcRn inhibitor technology, the Company is boldly developing innovative therapies for a range of debilitating autoimmune diseases with significant unmet patient needs.

Organizational Overview:

Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. As trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the complex and variable needs of people with autoimmune diseases.

The Role:

Reporting to the Vice President, IT & Facilities, this senior IT leader is responsible for the following: (1) build and scale corporate (G&A) and commercial business systems, including standing up the commercial systems landscape from the ground up ahead of launch, along with data, analytics, and AI capabilities; (2) partner closely with the IT PMO lead to build out project and portfolio management across IT and the business; (3) serve as a trusted business partner to leaders in Finance, HR, Legal, Compliance, and Commercial, managing stakeholder relationships and translating business goals into technology roadmaps and delivered solutions; and (4) support R&D initiatives and CSV-governed systems as needed, in partnership with the Sr. Director, R&D Business Systems. This is a hands-on leadership role for a proven builder who establishes new capabilities, leads effectively through strategic vendor partnerships, and consistently delivers measurable results.

Key Responsibilities:

Corporate & Commercial Business Systems

- Serve as IT business partner to Finance, HR, Legal, Compliance, and Commercial leadership; own and execute the corporate and commercial systems roadmap, including build/buy decisions, prioritization, and budget.
- Lead the stand-up of the IT infrastructure supporting the commercial technology ecosystem for launch, partnering with Commercial Operations
- Build out and scale the G&A applications portfolio: Finance/ERP and procure-to-pay, HR/HCM, Legal and Compliance, and collaboration platforms, including integrations and IT controls.
- Shape enterprise data and innovation capabilities, including IT architecture and vendor-supported data warehousing, in partnership with Commercial Operations while enabling practical adoption of AI and other emerging technologies.
- Personally drive implementations end to end, from requirements and design through testing, cutover, and hypercare, and build sustainable support models.

IT PMO Partnership

- Partner closely with the IT PMO lead to build, enhance, and mature the PMO function within IT and across the business.
- Design and run demand intake and portfolio prioritization, and stand up governance forums with business and IT leadership.
- Build and run portfolio reporting, including status dashboards, resource and capacity views, and budget tracking, to give leadership clear visibility into delivery, risks, and value.
- Extend project management practices to business-led initiatives, coaching functional teams on planning, execution, and change management.

Vendor Management & Delivery

- Lead through implementation partners, managed service providers, and SaaS vendors; define SOWs and success criteria, negotiate contracts with Procurement and Legal, and hold partners accountable to SLAs.
- Drive on-time, on-budget delivery with clear executive-level communication.

R&D / GxP Partnership & Compliance

- Support the Sr. Director, R&D Business Systems with initiatives as needed, including implementation, validation, and audit and inspection readiness.
- Apply risk-based CSV/CSA practices in line with the IT QMS; ensure data security, integrity, and privacy with IT Security and vendors.
- Collaborate across IT and contribute to IT strategy, standards, and budget as a member of the IT leadership team.

Requirements:

- Bachelor’s degree in Information Technology, Computer Science, Business, or a related field.
- 12+ years of biopharma IT experience; commercial systems and product launch experience preferred.
- Proven experience building G&A and commercial systems, including ERP, P2P, HCM, CRM, data, BI, and AI capabilities; Veeva and NetSuite experience strongly preferred.
- Experience leading PMO, technical project, and vendor management activities across complex, multi-vendor programs; PMP or similar certification preferred.
- Strong knowledge of CSV/CSA, GxP, and biopharma IT regulatory and compliance requirements.
- Executive-level business partner and hands-on builder who communicates effectively, influences stakeholders, and delivers in a fast-paced, resource-lean environment.

Work Environment:

- Remote-based
- Dynamic, interactive, fast-paced, and entrepreneurial environment
- Domestic travel is required (approximately 10%)

Salary range for posting $260,000—$295,000 USD

Compensation is based on a number of factors, including market location, and may vary depending on job-related knowledge, skills, and experience. Equity and other forms of compensation may be provided as part of a total compensation package, in addition to a full range of medical, dental, vision, 401k, and other benefits, including unlimited paid time off and parental leave.

## About IMVT Corporation

## Company Overview
- **One-liner**: A clinical-stage immunology company developing innovative anti-FcRn therapies to enable normal lives for people with autoimmune diseases.
- **Entity Type**: Public (Nasdaq: IMVT)
- **Headquarters**: Durham, North Carolina, United States
- **Founded**: Not publicly available
- **Founders**: Not publicly available

## Core Business
- **Primary industry**: Biotechnology / Autoimmune disease therapeutics
- **Target customers**: Patients with IgG-mediated autoimmune diseases; healthcare providers; payers (B2B/B2C mix via prescription drugs)
- **Mission or purpose statement**: “Dedicated to enabling normal lives for people with autoimmune diseases” [immunovant.com](https://www.immunovant.com/)

## Products & Services
- **[IMVT-1402 (imeroprubart)]**: A novel, fully human monoclonal antibody that targets FcRn to reduce pathogenic IgG autoantibodies. Designed as a subcutaneous injection with a simple autoinjector (YpsoMate®). In clinical development for six indications: Graves’ disease (GD), difficult-to-treat rheumatoid arthritis (D2T RA), myasthenia gravis (MG), chronic inflammatory demyelinating polyneuropathy (CIDP), Sjögren’s disease (SjD), and cutaneous lupus erythematosus (CLE). [10-K (2026)](https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf)
- **[Batoclimab (first-generation anti-FcRn)]**: Development discontinued across all indications after Phase 3 TED trials did not meet primary endpoints; learnings inform IMVT-1402 program. [10-K (2026)](https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf)

## Market Standing
- **Valuation/Market Cap**: Not disclosed in available sources (publicly traded on Nasdaq; refer to real-time market data).
- **Key Metric**: Clinical-stage company with no approved products or revenue; total funding and operating expenses are detailed in SEC filings but not summarized here.
- **Notable Investors/Partners**: HanAll Biopharma (collaboration on anti-FcRn antibodies); Ypsomed AG (auto-injector YpsoMate®). [10-K (2026)](https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf)
- **Growth Signals**: Six ongoing clinical programs (including potentially registrational trials); deep IgG reductions (~80% with weekly 600 mg IMVT-1402) suggesting best-in-class potential; Phase 1 safety data showing no/minimal albumin reduction or LDL cholesterol increases. [10-K (2026)](https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf)

## Competitive Advantages
- **Potential best-in-class efficacy**: IMVT-1402 achieves deeper IgG reductions than competitor anti-FcRn antibodies, correlating with improved clinical outcomes.
- **Favorable safety profile**: No or minimal off-target effects on albumin and LDL cholesterol, unlike some FcRn inhibitors.
- **Convenient administration**: Self-administered subcutaneous autoinjector (YpsoMate®) expected at launch, improving patient adherence.
- **Broad pipeline**: Six indications in development across endocrinology, rheumatology, neurology, and dermatology, with potential for more.

## Strategic Focus
- Execute pivotal trials for IMVT-1402 in GD, D2T RA, MG, CIDP, SjD, and CLE.
- Leverage learnings from batoclimab program to accelerate IMVT-1402 development.
- Plan to assess new indications for IMVT-1402 beyond the initial six.
- Continue to build commercial capabilities for eventual launch. [10-K (2026)](https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf)

## Why Work Here
- **Culture**: Emphasizes “Hire and Retain Only the Very Best,” “One Team, Shared Success,” “Ownership Mentality,” and “Patients Are Waiting” – a mission-driven, high-performance environment. [About Us](https://www.immunovant.com/about-us)
- **Remote/Hybrid Policy**: Job listings show a mix of remote and hybrid roles (e.g., “Remote” for many positions, “Hybrid - NYC” for commercial roles). [Careers](https://www.immunovant.com/join-us/explore-careers)
- **Notable Perks**: Merit-based recognition, focus on impact and results, creative problem-solving encouraged. [About Us](https://www.immunovant.com/about-us)
- **Engineering/Science Culture**: Clinical-stage biotech with cutting-edge FcRn technology; opportunities in clinical development, biometrics, quality assurance, and commercial roles. [Careers](https://www.immunovant.com/join-us/explore-careers)

## Sources
1. [Immunovant Corporate Website](https://www.immunovant.com/)
2. [About Us – Values and Culture](https://www.immunovant.com/about-us)
3. [Company Information – Investor Relations](https://www.immunovant.com/investors/company-information)
4. [Explore Careers – Job Listings](https://www.immunovant.com/join-us/explore-careers)
5. [10-K SEC Filing (May 20, 2026)](https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf)

## Other roles at IMVT Corporation

- [Associate Director, Biostatistics](https://feeny.ai/job/associate-director-biostatistics-imvt-corporation-remote-dgj2yvz4mm9k)
- [Senior Manager, Medical Communications](https://feeny.ai/job/senior-manager-medical-communications-imvt-corporation-remote-s03pz93xa8tp)
- [Executive Director, Marketing](https://feeny.ai/job/executive-director-marketing-imvt-corporation-remote-sc5ja0w76sbv)
- [Executive Director, New Product Planning](https://feeny.ai/job/executive-director-new-product-planning-imvt-corporation-remote-hek53s90egtb)
- [Director, Infrastructure & Data Platforms](https://feeny.ai/job/director-infrastructure-data-platforms-imvt-corporation-remote-vcb6ytpndm32)
- [Director, Supply Chain Product Planning](https://feeny.ai/job/director-supply-chain-product-planning-imvt-corporation-remote-a4ek4z6agfre)
- [Senior Manager, Statistical Programming](https://feeny.ai/job/senior-manager-statistical-programming-imvt-corporation-remote-6q5z9h7nwxvn)
- [Director, Financial Planning & Analysis](https://feeny.ai/job/director-financial-planning-analysis-imvt-corporation-remote-2xtk0zhd4zbr)
- [Executive Assistant](https://feeny.ai/job/executive-assistant-imvt-corporation-new-york-m7dv0wr8rkjs) — New York, NY
- [Director, Medical Science Liaison (MSL)](https://feeny.ai/job/director-medical-science-liaison-msl-imvt-corporation-southeast-cnykwbftkpjw) — Southeast, United States